Trial Profile
A Phase IV Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of 1.0 mg/kg Efalizumab in Adult Patients With Moderate to Severe Plaque Psoriasis Involving the Hands and/or Feet
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Feb 2017
Price :
$35
*
At a glance
- Drugs Efalizumab (Primary)
- Indications Plaque psoriasis
- Focus Therapeutic Use
- Sponsors Genentech
- 23 Oct 2014 New trial record